McBride PLC
LSE:MCB

Watchlist Manager
McBride PLC Logo
McBride PLC
LSE:MCB
Watchlist
Price: 144.8 GBX -3.34% Market Closed
Market Cap: £256.2m

McBride PLC
Investor Relations

McBride Plc is a manufacturer and supplier of contract manufactured and private label products for the domestic household and professional cleaning/hygiene markets. The firm's segments include Liquids, Powders, Unit dosing, Aerosols and Asia Pacific. The Liquids segment involves anything sold in a bottle or pouch, such as washing up liquid, bleach, disinfecting sprays. The Powders segment consists of laundry powders, but with some auto dishwasher powder products. The Unit Dosing segment includes single-use products, such as auto dishwasher tablets and laundry capsules. The Aerosols segment produces a range of household, personal care and professional cleaning products discharged from a pressurized can. The firm's various brands include Surcare, Oven Pride, Clean n Fresh, Hospec and Actiff. The company operates approximately 15 manufacturing facilities in Europe and Asia.

Show more
Loading
MCB
FTSE All Share Index
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
Feb 26, 2026
AI Summary
Q2 2026

Revenue: Sales increased just under 1% to GBP 475 million for the half year, with growth in private label and contract manufacturing volumes.

Profitability: EBITDA margins remained just under 9%, consistent with last year, despite competitive and inflationary pressures.

Transformation: The first SAP S/4HANA go-live in the UK was completed, an important milestone in McBride’s digital transformation.

Shareholder Returns: Nearly GBP 13 million deployed for dividends, share buybacks, and reducing future dilution from employee share awards.

Market Share: Private label volume share in key European markets rose to 36.1%, up 0.3% over the last four quarters.

Guidance: Management expects full year results to be in line with analyst expectations.

Outlook: The company remains optimistic, with a strong pipeline of new business and continued focus on capital allocation and operational improvements.

Key Financials
Revenue
GBP 475 million
EBITDA
GBP 41.8 million
EBITDA Margin
just under 9%
Adjusted Operating Profit
GBP 31.5 million
Earnings Per Share
10.8p per share
Free Cash Flow
GBP 24 million
Net Debt
GBP 120.6 million
Private Label Volume Share
36.1%
Capital Expenditure
GBP 14.8 million
Dividends Paid
GBP 5.2 million
Share Buybacks
GBP 1.3 million
Employee Benefit Trust Share Purchases
GBP 6.4 million
Other Earnings Calls
2026

Management

Mr. Christopher Ian Charles Smith ACA
CEO & Executive Director
No Bio Available
Mr. Mark William Strickland
CFO & Director
No Bio Available
Mr. Robert Peter Henry
General Counsel & Company Secretary
No Bio Available
Mr. Peter Ingelse
Managing Director of Liquids
No Bio Available
Mr. Lennard Markestein
Managing Director of Unit Dosing
No Bio Available
Marielle Claudon
Managing Director of Powders
No Bio Available

Contacts

Address
MANCHESTER
Middleton Way
Contacts
+441616539037.0
www.mcbride.co.uk
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett